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Dear Editor,
In a comment to our article entitled ‘‘Forecasting Phar-
maceutical Prices for Economic Evaluations When There
Is No Market: A Review’’, which was recently published in
PharmacoEconomics - Open [1], Holko stated that market-
specific aspects could affect efficiency of forecasting price
using the price of a close substitute [2]. We thank the
author for the comment on our article and agree that there
are differences in prices between countries and these are
additional considerations for the analysis. The price of the
close substitute may differ considerably between countries,
which could affect the estimated price of the study drug
and the cost-effectiveness analysis.
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